Studies the relationship between food, diet, and health, and it aims to promote healthy eating habits and prevent nutritional deficiencies and chronic diseases.
Leading the way in cutting-edge therapies that improve quality of life and address unmet medical needs.
Our expert team finds, develops, and delivers high-quality treatments for patients around the world.
Serving patients globally by providing access to life-changing pharmaceutical products and therapies.
Nasgen is a biopharmaceutical company committed to advancing the concept of health through innovative research, development, and commercialization of novel therapeutic solutions.
To develop transformative health solutions that improve global health and enhance the well-being of individuals and communities.
To be a global leader in biopharmaceutical innovation, committed to advancing health, improving quality of life, and addressing critical medical needs.
NASGEN group has subsidiaries in KSA, UAE and SUDAN covering the entire geographical region and as hubs for the international business, KSA hub for GCC and ME market, UAE hub for export market and SUDAN hub for AFRICA market.
Synergy is a biopharmaceutical company operating in Sudan, focused on improving health outcomes through cutting-edge research and the introduction of innovative therapies. With expertise in developing and delivering high-impact treatments across key therapeutic areas, Synergy works closely with healthcare providers to ensure ethical, efficient, and patient-focused care. Its deep understanding of regional healthcare needs is matched by a commitment to global standards in quality and regulatory excellence.
Al Arjoun is a leading biopharmaceutical company based in the Kingdom of Saudi Arabia, dedicated to the research, development, and delivery of novel therapeutic solutions. With a focus on critical therapeutic areas such as Cardiology, Neurology, and Oncology, Al Arjoun combines innovative science with a strong commitment to patient well-being. The company also specializes in navigating regulatory pathways and implementing patient-centric support programs to ensure access to high-quality care across the region.
The Dubai Branch serves as a dynamic gateway for expanding operations across the GCC and international markets. Positioned at the crossroads of global healthcare innovation, the branch plays a vital role in facilitating regulatory alignment, business development, and strategic partnerships. With access to a highly connected business ecosystem and a focus on biopharmaceutical advancement, the Dubai Branch supports efficient commercialization pathways and ensures agile market access for novel therapeutic solutions.
NASGEN team has more than 28 years of cumulative and diversified experience in the field of pharmaceutical, biological, medical and healthcare industries in KSA, GCC, MENA and IRAN markets, with the deep knowledge of the market dynamics and drivers.
It spans a wide spectrum of therapeutic areas, such as Cardiology, Neurology, Oncology, Anesthetics, Anti-infectives, and respiratory.
Studies the relationship between food, diet, and health, and it aims to promote healthy eating habits and prevent nutritional deficiencies and chronic diseases.
Used for the prevention, treatment, or management of various medical conditions, including autoimmune diseases, cancer, and infectious
Our product portfolio spans a wide range of applications, from diagnostic equipment to therapeutic devices, all designed with patient safety and comfort in mind. .
At Nasgen, your questions, feedback, and inquiries matter to us. Whether you’re seeking more information about our products, exploring partnership opportunities, or simply want to learn more about what we do, our team is ready to assist you.
© Copyright 2024 by Nasgen.co